Home
OrbiMed Capital GP VII, Director: Enliven Therapeutics ELVN Sell · Filed 24/05/20
Trade details
- Type
- Insider sale
- Amount
- $22,140,000
- Shares · price
- 1,000,000 sh · $22.14 a share
- Held after
- 7,663,349 sh
- Trade date
- 24/05/16
- Filed
- 24/05/20
- Days to filing
- 4 days
Sold 11.5% of holdings
- Share of holding sold
- 11.5%
Enliven Therapeutics trades, last 26 weeks
What else happened in Enliven Therapeutics around then
Filed or reported within 30 days of the trade day · 24/04/16~24/06/15OrbiMed Capital GP VII's recent trades
- OrbiMed Capital GP VII
BuyADARx Pharmaceuticals
BuyADARx Pharmaceuticals
ADRX
$10M
588,235 sh
$10M
Filed 09/30
Traded 09/28
- OrbiMed Capital GP VII
BuyADARx Pharmaceuticals
BuyADARx Pharmaceuticals
ADRX
$5.1M
300,249 sh
$5.1M
Filed 09/30
Traded 09/28
- OrbiMed Capital GP VII
BuyADARx Pharmaceuticals
BuyADARx Pharmaceuticals
ADRX
$1M
61,516 sh
$1M
Filed 09/30
Traded 09/28
- OrbiMed Capital GP VII
BuyElectra Therapeutics
BuyElectra Therapeutics
ETRA
$15M
1,000,000 sh
$15M
Filed 09/23
Traded 09/21
- OrbiMed Capital GP VII
BuyElectra Therapeutics
BuyElectra Therapeutics
ETRA
$5M
333,333 sh
$5M
Filed 09/23
Traded 09/21
